Bird & Bird has advised Biocentis on the deal, while DWF has assisted Algebris Investments. Biocentis, a life science company specialising in genetic innovation, has completed...
Biocentis Raises $19 Million to Advance Programmable Insect Control
PACT Earth Secures $20 Million in Series A Financing to Scale Biomaterials Technology
Bird & Bird has advised PACT Earth. PACT Earth has successfully concluded a $20 million Series A fundraising round to support the scale-up of its innovative...
FUJIFILM Healthcare UK Acquires Endoscopy Business from Aquilant Endoscopy
Bird & Bird has advised FUJIFILM Healthcare UK Limited (HCUK). FUJIFILM Healthcare UK Limited (HCUK) has completed the acquisition of the endoscopy business operated by Aquilant...
Paladin Capital Leads $26.2 Million Series B Investment in Mimica
Bird & Bird has advised Paladin Capital Group. Paladin Capital Group has led a $26.2 million Series B investment in Mimica, a process intelligence company, with...
Everystate Completes Seed Funding Round Backed by Era.vc
Bird & Bird has advised Everystate Ltd. Everystate Ltd, a wellness brand, has completed a seed funding round with investment from Era.vc. The transaction marks an...
Herspiegel’s Acquisition of FIECON
Bird & Bird advised FIECON on the deal. Herspiegel, a world leader in pharmaceutical and biotech commercialization services, continues its strategic expansion by joining forces with...
LoQus23 Therapeutics’ £35 Million Series A Financing Round
Bird & Bird has advised lead investor Forbion on the deal. Forbion completed the £35 million (c.$43 million) Series A financing in LoQus23 Therapeutics, to advance...
Envision’s Acquisition of OKRA.ai
Goodwin advised OKRA.ai on the deal. Bird & Bird and Ropes & Gray advised Envision Pharma Group. OKRA.ai announced their acquisition by Envision Pharma Group (Envision). Envision...
Hack The Box’s $55 Million Series B Investment Round
White & Case LLP has advised Carlyle as lead investor on the Series B investment round in Hack The Box, advised by Marriott Harrison. Bird &...
Amphista Therapeutics’ Series B Extension Investment
Bird & Bird has advised the Dementia Discovery Fund on the deal. The investment will enable Amphista to accelerate the application of its technology into indications...
Supernal’s Investment in Urban-Air Port Ltd
Bird & Bird advised Urban-Air Port Ltd on the deal. Urban-Air Port Ltd (UAP) received a landmark investment from Supernal, previously the Urban Air Mobility Division...
Iksuda Therapeutics’ £29.6 Million Series A Financing Round
Ashfords advised life sciences company Iksuda Therapeutics on the deal. Bird & Bird advised Mirae Asset Capital, Celltrion and Premier Partners. Iksuda is the developer of...